Empa 10MG T-005
Empa 10MG T-005
Empa 10MG T-005
Tablet Section
Product Name: EMPA 10MG Tablet
1 Batch Number: T-005
Instruction:
1. Fill the BMR accurately, avoid cutting & overwriting. In case of any mistake/ error, cut that word or line with a single stroke and do initials there.
2. Check the materials for their identity (by name, Batch no and Release status) and quantity.
3. Ensure line clearance prior to start of each process.
4. Ensure compliance of environmental conditions (Temperature, Relative Humidity and Differential Pressure) during all manufacturing operations whenever necessary.
5. Use mask, Gloves, cap and uniform during process. (As per requirement)
6. Do not touch any moving parts of the machine while in operation. Use all the electrical board/panel carefully and keep away from any spillage.
7. Strictly follow all the steps of standard operating procedures.
8. Make sure all safety guards and side panels are in position before and after starting machine.
9. In case of any deviation, immediately inform and get permission from senior corrective and preventive action and document all the deviations.
10. Product Status of all the steps of manufacturing and packing operations must be displayed.
Note: All the equipment and utensils must be properly cleaned and properly labeled.
API Empagliflozin................10 mg
Each film coated tablet contains:
Label Claim Empagliflozin.......... 10mg
(Innovator’s Specifications)
Weight of API per batch(kg) = mg/Tablet x batch size = 20.08 g/batch size
1000g
Empagliflozin
20.00 gm 20.04 gm
Lactose monohydrate 190.47 gm 190.47 gm
Starch 101.71gm 101.71gm
PVP K 30 8.60 gm 8.6 gm
Primojel 4.00 gm 4.00 gm
Magnesium stearate 10.22 gm 10.22 gm
Avicel-102 82.20 gm 82.20 gm
Aerosil-200 3.00 gm 3.00 gm
Coating Material Dispensing
Checked Received By
Qty. Additional Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Qty Issued By Pharmacist Pharmacist
Empagliflozin
20.00 gm 20.04 gm
Lactose monohydrate 190.47 gm 190.47 gm
Starch 101.71gm 101.71gm
PVP K 30 8.60 gm 8.60 gm
Primojel 4.00 gm 4.00 gm
Magnesium stearate 10.22 gm 10.22 gm
Avicel-102 82.20 gm 82.20 gm
Aerosil-200 3.00 gm 3.00 gm
Coating Material Dispensing
Checked Received By
Qty. Additional Dispensed Verified
QC. No Raw Materials Qty. Issued Return Actual Used By Disp.
By QA Officer
Production
Reqd. Qty Issued By Pharmacist Pharmacist
03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?
04 Are Personnel in the dispensing room wearing specified cleaned uniform, gloves and mask?
Is Temperature and relative humidity in accordance with the requirements and recorded?
05
Temperature:_______(°C) & Humidity:_________(%)
06 Are log books maintained properly?
07 Are weighing balances in calibrated status?
08 Is Differential Pressure in accordance with the requirements and recorded?
09 Is dispensing hood properly in working condition?
10 Are all dispensing tools used in dispensing, properly cleaned and wrapped in polythene bag having cleaned status?
11 Are Raw materials to be dispensed having proper identification label and QC release?
12 Is approved manufacturing order pertaining to the batch to be dispensed, available and as per requiBlack batch size?
13 Are Dispensing tags available as per manufacturing order?
All the above parameters are checked and found satisfactory
PRODUCTION PHARMACIST _______________ DATE & TIME:_______________ LINE CLEARANCE AWARDED: YES □ NO □
QA OFFICER ___________________ DATE & TIME:________________ REMARKS: _______________________
LINE CLEARANCE FOR MORE THAN ONE TIME AFTER RECHECKING OF ABOVE PARAMETERS EACH TIME
DATE TIME LINE CLEARANCE STATUS CHECKED BY RECHECKED BY IPQC
Sr. Equipment ID
Description Cleaning Status
#
Sigma Mixer BM/R&D/001
1
Rotary wet granulator BM/R&D/002
2
Powder tray dryer BM/R&D/003
3
Oscillating Dry granulator BM/R&D/004
4
5 Double cone mixer BM/R&D/005
6 Rotary tablet press ZP-17 BM/R&D/006
7 Dust collector -----
8 Double jacket coating mixer BM/R&D/007
9 Coating pan SS BM/R&D/008
10 ALU-ALU blister machine 4001
11 LASER Jet printer 4003
12 Conveyer belt 4002
All the above mentioned equipment are checked and found in proper working condition.
PRODUCTION PHARMACIST _______________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER ___________________ DATE & TIME:________________ REMARKS: _______________________
LINE clearance for more than one time after rechecking of above parameters each time
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Date Time Line clearance status Checked by Rechecked by IPQC
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 10 of 48
BRIELL PHARMACEUTICALS R&D Dept.
6 SIEVING :
After drying, fix _____ # mesh on oscillating granulator and pass the dried material through it. Collect the grains in
polythene lined labeled containers.
Sieving Started at: _________ Sieving Completed at: _________
Total Sieving Time: ________ Date:__________
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section After Drying
Filled By Quality Assurance
Date: Time: Sampled By: Quantity: QA Officer (Sign)
Remarks: _________________________________________________________________________
Note: Store the grains with proper Air tight Polythene bags in labeled containers in in-process Quarantine Area.
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Final mixing
Filled By Quality Assurance
Date: Time: Sampled By: Quantity: QA Officer (Sign)
Remarks: _________________________________________________________________________
LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
PRODUCT SPECIFICATIONS (CORE TABLETS)
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 18 of 48
BRIELL PHARMACEUTICALS R&D Dept.
Physical Appearance: White Colored One Side Engraved Cut line Round Tablet
Punch Shape: Round
Punch size: 8 mm
Average weight: 210mg / tablet
Weight variation Limit: ± 7.5 %
Range: 194.25-225.75mg
Diameter: 8±0.04mm
Thickness: 5±0.04mm
Hardness: NMT 10 kg
Disintegration time: NMT 15 mint
Friability: NMT 1 %
Dies & Punches should be checked for proper fitting. Tablets of first round checked by Production Pharmacist (all physical parameters except disintegration) and after
machine adjustment Production pharmacist will send intimation to concerned QA Officer to collect sample for physical analysis such as Appearance, Diameter, Thickness,
Hardness, Friability, Average Wt., Disintegration Time, and Wt. Variation of tablets.
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Compression
Filled By Quality Assurance
Date: Time: Sampled By Quantity QA Officer (Sign)
Remarks ( if any ) :
Date: ______________
Container Tare Weight Net Weight Checked By Production Verified By QA
Gross Weight (Kg) Performed By Operator
Number (Kg) (Kg) Pharmacist Officer
1
4
TOTAL NET WEIGHT _________________Kg.
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
Yes No Yes No
Sr. # CLEARANCE PARAMETERS
01 Is area properly cleaned and labeled?
02 Are there any traces of previous Product _______________ Batch #_________ in
a- Area, Containers, Stools, S.S bowl
b- Conventional Coating Pan
START UP OPERATION
03 Are equipment & containers properly cleaned & labeled with Equipment / Product Identification Label?
04 Are personnel in the blistering room wearing specified clean uniform, gloves and mask?
05 QC release of the batch to be processed is present?
06 Is coating machine specific parts (gauges) in calibration status?
Are Temperature and relative humidity in accordance to the requirements and recorded?
07 Temperature:_______(°C) & Humidity:_________(%)
08 Is documentation of previous stages completed?
All the above parameters are checked and found satisfactory.
PRODUCTION PHARMACIST: _____________ DATE & TIME:_______________ Line Clearance awarded: YES □ NO □
QA OFFICER: _________________ DATE & TIME:________________ REMARKS: _________________________________
LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC
COATING:
Dedust the core tablets before loading into the pan. Load the core tablet in the Coating pan using SS Bowl. Switch ON the
main power supply & warm the cores for 5 minutes.
Spray the coating solution on tablet bed till all the solution is used. Adjust and maintain the following parameters during
coating.
Coating started at: ____________ Coating completed at: _________
Total Coating Time : _________ Date:__________
After complete coating, transfer the coated tablets from coating pan in the tarred containers equipped with clean polythene
bags. Send request to QA for sampling for physical and chemical analysis & calculate %age weight gain & %age yield.
Note: Store the coated tablets in proper Air tight Polythene bags, in labeled containers, in in-process Quarantine Area
Date: ______________
Product Name: EMPA 10MG Tablet Batch No: T-005
Mfg. Date: 05-2022 Expiry Date: 04-2024
Batch Size: 420.246gm Batch Quantity: 2000tab
Product Reg. No: ----- Shelf Life: 24months
Section: General Tablet Section Memo: Trail
Prepared By: __________ Reviewed By:______________ Verified By: ____________ Approved By: ___________
Section Incharge Production Manager Store Incharge QC Manager
Prepared By: __________ Reviewed By:______________ Verified By: ____________ Approved By: ___________
Section Incharge Production Manager Store Incharge QC Manager
LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC
EMBOSSING INFORMATION
Batch No.& Expiry Date
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
T-005 EXP 04-2024
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
Attach Verified Embossed Empty Blister Specimen Here
RED
Attach First STAMP INDICATES ORIGIONAL DOCUMENT
Blister Attach Second Blister Attach Third Blister
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 31 of 48
BRIELL PHARMACEUTICALS R&D Dept.
Bulk inspection of
Batch No. Exp. Date Leakage Test Cutting Text Printing
product
REMARKS: ________________________________________________________________________________
Production Pharmacist________________ QA Officer: ________________
Note: 1) QA officer will use Black ball point while Production officer will use Blue ball point.
2) In process entries are taken every 30 minutes by QA and production alternatively.
TEAM LAY OUT SHEET AT BLISTERING STAGE
Start
CONTROLLED Time:NO COPYING WITHOUT MANAGER Q.A PERMISSION
COPY: Close Time:
STAMP Start Date: Close Date:
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 33 of 48
BRIELL PHARMACEUTICALS R&D Dept.
START UP OPERATION
03 Are equipment & containers properly cleaned &labeled withEquipment / Product Identification Label?
04 Are personnel in the Printing room wearing specified clean uniform and mask?
05 Is printing machine specific parts (gauges) in calibration status?
Are Temperature and relative humidity in accordance to the requirements and recorded?
06
TEMP______HUMIDITY_____
07 Is QC released packaging material to be used for respective batch available?
08 Is documentation of previous stages completed?
09 Correct Printing of Batch no. ,Mfg Date &Expiry date .
_______________________
PRODUCTION OFFICER DATE &TIME:_______________ Line Clearance awarded: YES □ NO □
___________
QA OFFICER DATE &TIME:________________ REMARKS: ________________________________________________
LINE clearance for more than one time after rechecking of above parameters each time
Date Time Line clearance status Checked by Rechecked by IPQC
__
CONTROLLED
IN-PROCESS CHECK COPY:PRINTING
SHEET FOR NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
Date STAMP Time B. No Mfg. Date Expiry Date M.R.P Rs. Checked by
RED STAMP INDICATES ORIGIONAL DOCUMENT
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 37 of 48
BRIELL PHARMACEUTICALS R&D Dept.
Prod. QA
Date
Operator
REMARKS: ________________________________________________________________________________
NOTE: 1) In process entries are taken after every 45 minutes by QA and Production alternatively.
2) QA officer will use Black ball point while Production officer will use Blue ball point.
CERTIFICATE OF ANALYSIS
Filled By Production
Date: Time: Section: Stage: Section Incharge (Sign)
General Tablet Section Finished
Filled By Quality Assurance
Date: Time: Sampled By Quantity QA Officer (Sign)
Remarks: _________________________________________________________________________
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
CONTROLLED COPY: NO COPYING WITHOUT MANAGER Q.A PERMISSION
STAMP
Checked By: ________________ VerifiedORIGIONAL
RED STAMP INDICATES By: _______________
DOCUMENT Approved By: ______________
RED STAMP INDICATES ORIGIONAL DOCUMENT
Page 43 of 48
BRIELL PHARMACEUTICALS R&D Dept.
Grand Total
Remarks: __________________________________________________________________________
Verified By: ____________
Section Incharge Production Manager Store Incharge
Remarks: __________________________________________________________________________________
Section Incharge Production Manager Store Incharge QA Manager
BATCH RECONCILIATION
1 Commercial Packs
2 QA Retained Samples
3 Left Over (If Any With Adjustment)
4 Theoretical Yield
5 Practical Yield
6 Process Wastage
7 Date Of Completion
Remarks:_______________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
________________________________________________________________________________________
DESTRUCTION NOTE
Remarks: _________________________________________________________________________